SCHEMBL12818304

SCHEMBL12818304

Cc1nc2ccc(S(=O)(=O)N3CCOc4ccc(-c5ccc(C#N)cc5)cc43)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.43
▸ PKLR P30613 1/20 0.43
▸ CYP2C9 P11712 2/20 0.40
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ PDE3B Q13370 4/20 0.36
▸ PDE3A Q14432 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HSPD1 P10809 1/20 0.35
▸ PTPN2 P17706 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818485 0.89 PDE3B (0.39) PKMPKLRCYP2C9MEN1KMT2A
SCHEMBL12818506 0.88 CYP2C9 (0.42) PKMPKLRCYP2C9MEN1KMT2A
SCHEMBL12818990 0.86 CYP2C9 (0.38) CYP2C9MEN1KMT2AALDH1A1CYP3A4
SCHEMBL12818912 0.85 PIK3CA (0.42) CYP2C9MEN1KMT2AALDH1A1CYP3A4
SCHEMBL12818327 0.83 CYP11B1 (0.38) PKMPKLRCYP11B1CYP11B2MAPT
SCHEMBL12818721 0.83 CYP2C9 (0.40) PKMPKLRCYP2C9MEN1KMT2A
SCHEMBL1818601 0.83 CYP2C9 (0.57) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL12818812 0.82 CYP2C9 (0.43) PKMCYP2C9MEN1KMT2AALDH1A1
SCHEMBL12818595 0.82 CYP11B1 (0.37) PKMPKLRCYP2C9CYP11B1CYP11B2
SCHEMBL12818598 0.82 CYP11B1 (0.37) PKMPKLRCYP2C9CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback